# Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

> **NCT00157547** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 95 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Selective serotonin reuptake inhibitors (SSRI)

## Key facts

- **NCT ID:** NCT00157547
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2008-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157547, "Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00157547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*